Loading organizations...
Key people at Prevent Cancer Foundation.
The Prevent Cancer Foundation is a non-profit dedicated to cancer prevention and early detection. It implements programs through research, public education, community outreach, and policy advocacy. These initiatives aim to reduce cancer incidence and improve patient outcomes by promoting proactive health strategies and providing accessible resources for informed health decisions.
Carolyn "Bo" Aldigé founded the organization in 1985, inspired by her father, Edward Perry Richardson's, death from cancer. Her insight stemmed from the prevailing medical focus on treatment rather than prevention. Aldigé recognized the urgent need for upstream interventions to mitigate suffering and decrease cancer's societal burden.
The Foundation serves the public, healthcare providers, and policymakers by disseminating crucial information and advocating for systemic change. Its vision projects a world where cancer is preventable, detectable, and ultimately beatable for everyone, fostering healthier communities globally through continuous dedication to its mission.
Key people at Prevent Cancer Foundation.
The Prevent Cancer Foundation is not a company—it is a 501(c)(3) nonprofit organization focused solely on cancer prevention and early detection.[2][3] The premise of your query contains an inaccuracy that should be clarified before proceeding with analysis.
The Prevent Cancer Foundation is the only U.S.-based nonprofit organization dedicated exclusively to cancer prevention and early detection.[2][5] Founded in 1985, the organization operates through research funding, education, community outreach, and advocacy to reduce cancer mortality across all populations, with particular emphasis on medically underserved communities.[2][3]
Rather than generating profit or returns for investors, the Foundation reinvests resources into its mission. Since its founding, it has invested more than $138 million in research, education, advocacy, and community outreach programs.[6] The organization aims to reduce cancer deaths by 40% by 2035, with plans to invest $20 million in early detection technology, $10 million to expand screening access for underserved communities, and $10 million in public education.[2]
The Prevent Cancer Foundation was established in 1985 by Carolyn Richardson Aldigé, following her father's battle with cancer.[4] Originally named the Cancer Research Foundation of America (CRFA), the organization evolved its identity to reflect its core mission: in 2002, it became the Cancer Research and Prevention Foundation, and in 2007, it adopted its current name to emphasize prevention.[4]
This founding story is significant because it positioned the Foundation as a pioneer in cancer prevention at a time when most organizations focused on treatment and cures.[3] The personal motivation behind its creation—a family member's cancer diagnosis—established the human-centered approach that continues to define its work today.
The Prevent Cancer Foundation operates at the intersection of public health, medical research, and health equity. Its emphasis on prevention and early detection addresses a critical gap in the healthcare ecosystem, where treatment-focused organizations dominate funding and attention. By investing in screening technologies, vaccination programs, and education for underserved populations, the Foundation helps democratize access to cancer prevention—a resource typically concentrated among affluent communities with better healthcare access.
The organization's advocacy work influences broader policy conversations around preventive medicine and pharmaceutical accessibility, positioning prevention as a viable and cost-effective alternative to treatment-focused healthcare models.
The Prevent Cancer Foundation's 2035 goal of reducing cancer deaths by 40% represents an ambitious commitment to measurable impact. Success will depend on scaling early detection technologies, expanding screening access to rural and low-income populations, and sustaining research momentum in multi-cancer screening innovations. As healthcare systems increasingly recognize the economic and human benefits of prevention, the Foundation's work becomes more strategically relevant—though its impact will ultimately be measured not in financial returns, but in lives saved and cancer incidence prevented.
